Home › Funds › LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA › IDXX
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA position in IDXX
IDEXX LABS INC · Health Care
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reported holding 114,834 shares of IDXX (IDEXX LABS INC) in its Q3 2026 13F filing — a position valued at US$60.0M, representing 0.55% of its reported portfolio and ranking #42 among its reported holdings. LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed IDXX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's IDXX position evolved
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA first disclosed a stake in IDXX in Q3 2023 at 150,364 shares (US$63.1M). The position peaked in Q4 2025 at 124,045 shares, worth US$86.2M. Across 13 filings, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 114,834 shares valued at US$60.0M — a reduction of -2,361 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 150.36K | $63.07M | New |
| Q4 2023 | 141.80K | $73.04M | Reduce |
| Q1 2024 | 140.28K | $67.27M | Reduce |
| Q2 2024 | 139.21K | $69.54M | Reduce |
| Q3 2024 | 134.83K | $60.98M | Reduce |
| Q4 2024 | 134.46K | $57.48M | Hold |
| Q1 2025 | 133.78K | $57.07M | Reduce |
| Q2 2025 | 131.68K | $70.63M | Reduce |
| Q3 2025 | 127.11K | $81.17M | Reduce |
| Q4 2025 | 124.05K | $86.18M | Reduce |
| Q1 2026 | 122.30K | $68.86M | Reduce |
| Q2 2026 | 117.19K | $61.70M | Reduce |
| Q3 2026 | 114.83K | $59.97M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IDXX and 13F data
IDXX (IDEXX LABS INC) is a Health Care company. 28 other funds we track also report a position in IDXX — the largest reported positions include Baron Funds (US$1.04B), BAMCO INC /NY/ (US$1.04B), Fundsmith LLP (US$536.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IDXX
- Baron Funds 1.98M sh · $1.04B · Q2 2026
- BAMCO INC /NY/ 1.98M sh · $1.04B · Q2 2026
- Fundsmith LLP 1.02M sh · $536.91M · Q2 2026
- BLAIR WILLIAM & CO/IL 847.32K sh · $442.46M · Q3 2026
More on LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
FAQ
How long has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA held IDXX?
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed IDXX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's current position in IDXX?
As of Q3 2026, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 114.83K shares of IDXX (IDEXX LABS INC), valued at $59.97M, representing 0.55% of its reported portfolio and ranking #42.
Has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA been buying or selling IDXX?
In the latest 13F filing (Q3 2026), LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reduced its position in IDXX. The position peaked in Q4 2025 at 124.05K shares.
Which other funds hold IDXX?
Other major institutional holders of IDXX include Baron Funds, BAMCO INC /NY/, Fundsmith LLP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.